Risks for OVID THERAPEUTICS INC (OVID)

Here are some interesting risks from the recent filings of OVID THERAPEUTICS INC. Our algorithms work hard to highlight risks unique to this company.

If we are not successful in discovering, developing and commercializing additional drug candidates, our ability to expand our business and achieve our strategic objectives would

Clinical trials are very expensive, time-consuming and difficult to design and implement.

Even if we obtain regulatory approval for our current or future drug candidates, they will remain subject to ongoing regulator

oval for our current or future drug candidates from the FDA, we may never obtain approval for our current or future drug candidates outside of the United States, which would limit our market opportunities and could harm our business.

Healthcare legislative reform measures may have a negative impact on our business and results of operations.